ProVerum Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 49

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $80M

  • Investors
  • 19

ProVerum General Information

Description

Manufacturer of a medical device intended to alleviate symptoms caused by an enlarged prostate. The company's flexible delivery system that uses 3-D geometry to engage prostate anatomy, providing radial force to the prostatic lobes without cutting, piercing, or heating tissue, with features including precise deployment under direct visualization, reversibility for removal at any time, an atraumatic design that reduces bleeding and the need for catheterization, and a universal fit to accommodate all indicated anatomies, enabling healthcare providers to treat patients experiencing urinary obstruction caused by prostate enlargement effectively.

Contact Information

Website
www.proverummedical.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2nd Floor, Astor Hall
  • 4-8 Eden Quay
  • Dublin D01 N5W8
  • Ireland
+353 (01)
Primary Industry
Therapeutic Devices
Other Industries
Diagnostic Equipment
Vertical(s)
Life Sciences
Corporate Office
  • 2nd Floor, Astor Hall
  • 4-8 Eden Quay
  • Dublin D01 N5W8
  • Ireland
+353 (01)

ProVerum Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ProVerum Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series B) 21-Aug-2025 $80M Completed Generating Revenue
9. Accelerator/Incubator Completed Generating Revenue
8. Later Stage VC (Series A) 23-Aug-2023 Completed Generating Revenue
7. Early Stage VC 23-Oct-2020 Completed Clinical Trials - Phase 1
6. Grant 12-Mar-2020 Completed Clinical Trials - Phase 1
5. Early Stage VC 02-Aug-2019 Completed Startup
4. Seed Round 08-May-2018 Completed Startup
3. Grant Completed Startup
2. Grant $591K Completed Startup
1. University Spin-Out 01-Jan-2016 Completed Startup
To view ProVerum’s complete valuation and funding history, request access »

ProVerum Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B Preferred
Series B Preferred
Series A
Preference
Preference
Preference
Preference 16,790 $0.001000 $132.5 $132.5 1x $132.5 3.43%
B Ordinary 6,764 $0.001000 $132.5 $132.5 1x $132.5 1.38%
To view ProVerum’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

ProVerum Patents

  • 158

    Total Documents Applications and Grants

  • Total Patents Families

  • 64

    Granted

  • 23

    Pending

  • Expiring in next 12 mo

ProVerum Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
DE-102025152546-A1 Floor covering element and manufacturing process for a floor covering element Pending 12-Feb-2025
DE-202025100105-U1 Device for processing surfaces Active 10-Jan-2025
DE-102025115282-A1 Floor covering element for adhesive installation Pending 19-Apr-2024
DE-102025115263-A1 Floor covering element for loose laying and manufacturing process for a floor covering element Pending 19-Apr-2024
AU-2024261760-A1 Device and method for deploying expandable implants Pending 27-Apr-2023 A61F2/9517
To view ProVerum’s complete patent history, request access »

ProVerum Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ProVerum Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds
Atlantic Bridge University Corporation Minority
Ireland Strategic Investment Fund Sovereign Wealth Fund Minority
IrishAngels Angel Group Minority
MVM Partners Growth/Expansion Minority
National Treasury Management Agency Asset Manager Minority
You’re viewing 5 of 19 investors. Get the full list »

Ready to get started?

Request a free trial

ProVerum FAQs

  • When was ProVerum founded?

    ProVerum was founded in 2016.

  • Where is ProVerum headquartered?

    ProVerum is headquartered in Dublin, Ireland.

  • What is the size of ProVerum?

    ProVerum has 49 total employees.

  • What industry is ProVerum in?

    ProVerum’s primary industry is Therapeutic Devices.

  • Is ProVerum a private or public company?

    ProVerum is a Private company.

  • What is the current valuation of ProVerum?

    The current valuation of ProVerum is .

  • What is ProVerum’s current revenue?

    The current revenue for ProVerum is .

  • How much funding has ProVerum raised over time?

    ProVerum has raised $124M.

  • Who are ProVerum’s investors?

    Atlantic Bridge University, Ireland Strategic Investment Fund, IrishAngels, MVM Partners, and National Treasury Management Agency are 5 of 19 investors who have invested in ProVerum.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process